Is there still room for large registrative trials in unselected cancer patients? The case of anti-epidermal growth factor receptor antibodies in advanced non-small-cell lung cancer

Author： Di Maio Massimo  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.11, Iss.9, 2011-09, pp. : 1131-1133

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IMC-C225, an anti-epidermal growth factor receptor monoclonal antibody, for treatment of head and neck cancer

By Herbst Roy S   Kim Edward S   Harari Paul M  

Expert Opinion on Biological Therapy, Vol. 1, Iss. 4, 2001-07 ,pp. : 719-732

Informa Healthcare

Access to resources Recommend Favorite

Detection of disease specific sialoglycoconjugate specific antibodies in bronchoalveolar lavage fluid of non-small cell lung cancer patients

By Mehta Sangeeta   Chhetra Rakhee   Srinivasan Radhika   Sharma Suresh   Behera Digambar   Ghosh Sujata  

Glycoconjugate Journal, Vol. 27, Iss. 5, 2010-07 ,pp. : 491-500

Springer Publishing Company

Access to resources Recommend Favorite

A review of vaccine clinical trials for non-small cell lung cancer

By Nemunaitis J   Nemunaitis J  

Expert Opinion on Biological Therapy, Vol. 7, Iss. 1, 2007-01 ,pp. : 89-102

Informa Healthcare

Access to resources Recommend Favorite

Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549

By Wang Ying  

Molecular Biology Reports, Vol. 40, Iss. 4, 2013-04 ,pp. : 3093-3099

Springer Publishing Company

Access to resources Recommend Favorite

Molecular Markers of Various Stages of Non-Small-Cell Lung Cancer

By Zborovskaya I. B.   Tatosyan A. G.  

Molecular Biology, Vol. 38, Iss. 2, 2004-03 ,pp. : 155-164

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite